Xiangyang Zhang - Concepedia

Author

Xiangyang Zhang

Institute of Psychology, Chinese Academy of Sciences ORCID

Also Known As

*Xiangyang Zhang, Keming Gao, ShuQiao Yao, T KOSTEN, X ZHANG, X. Y. Zhang, Xiang Yang Zhang, Xiang yang Zhang, Xiang-Yang Zhang, Xiang-yang Zhang

515

Publications

12.1K

Citations

H-Index

259

Concepts

All Affiliations

Institute of Psychology, Chinese Academy of Sciences Peking University Beijing HuiLongGuan Hospital University of Chinese Academy of Sciences Baylor College of Medicine

About

Xiangyang Zhang is an author at Institute of Psychology, Chinese Academy of Sciences specializing in medicine, psychiatry, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	8	8	216
2	Engineering	6	6	165
3	Business	1	1	17
4	Education	1	1	77
5	Language Studies	1	1	19

Xiangyang Zhang

266

Publications

10.7K

Citations

H-Index

Page 1

	Year	Citations
Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis Cheng Wang, Yulei Li, Lei Shi, Nature Genetics Molecular NeuroscienceSignal TransductionMendelian DisorderGenetic DisorderMedicine	2012	407
Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics Xiangyang Zhang, Yun Tan, Lian Yuan Cao, Schizophrenia Research Psychoactive DrugPsychiatryAtypical AntipsychoticsMedicinePsychotropic Medication	2005	263
The prevalence and risk factors of psychological disturbances of frontline medical staff in china under the COVID-19 epidemic: Workload should be concerned Yongjie Zhou, Wenjuan Wang, Yanping Sun, Journal of Affective Disorders NursingPsychiatryFrontline Medical StaffPatient SafetyWork-related Stress	2020	209
Identifying a clinical signature of suicidality among patients with mood disorders: A pilot study using a machine learning approach Ives Cavalcante Passos, Benson Mwangi, Bo Cao, Journal of Affective Disorders Pilot StudyHealth InformaticsPsychopathologyPsychiatryMood Symptom	2016	189
Changes in Serum Interleukin-2, -6, and -8 Levels Before and During Treatment With Risperidone and Haloperidol Xiangyang Zhang, Dong Zhou, Lian Yuan Cao, The Journal of Clinical Psychiatry	2004	180
Increased Phospholipase A2 Activity and Inflammatory Response But Decreased Nerve Growth Factor Expression in the Olfactory Bulbectomized Rat Model of Depression: Effects of Chronic Ethyl-Eicosapentaenoate Treatment Cai Song, Xiangyang Zhang, Mehar S. Manku Journal of Neuroscience	2009	168
Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics Mei Hong Xiu, Li Hui, Yu Feng Dang, Progress in Neuro-Psychopharmacology and Biological Psychiatry PsychiatryPsychotic DisorderAtypical AntipsychoticsMedicinePsychotropic Medication	2009	166
Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity Bo Cao, Raymond Y. Cho, Dachun Chen, Molecular Psychiatry Neuroimaging BiomarkersTreatment Response PredictionBrain Functional ConnectivityPsychiatryPsychotic Disorder	2018	150
Psychological Resilience as a Protective Factor for Depression and Anxiety Among the Public During the Outbreak of COVID-19 Shasha Song, Xin Yang, Hua Yang, Frontiers in Psychology	2021	149
Prevalence, risk factors and clinical correlates of depression in quarantined population during the COVID-19 outbreak Min Peng, Beirong Mo, Yansong Liu, Journal of Affective Disorders PsychiatryCovid-19 PandemicDepressionCovid-19 OutbreakDisease Outbreak	2020	136

Page 1